Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12385241 | 0.82 | GAA (0.46) | GAAL3MBTL1KDM4EKMT2AALDH1A1 | |
| SCHEMBL14409879 | 0.78 | GAA (0.43) | GAAL3MBTL1KDM4EKMT2AALDH1A1 | |
| SCHEMBL579263 | 0.77 | — | — | |
| SCHEMBL21147718 | 0.77 | KDM4E (0.33) | GAAKDM4EKMT2A | |
| SCHEMBL25431167 | 0.75 | — | — | |
| SCHEMBL15628407 | 0.75 | — | — | |
| SCHEMBL1312735 | 0.75 | CA1 (0.36) | GAAKDM4E | |
| SCHEMBL12200996 | 0.75 | GAA (0.40) | GAAL3MBTL1KDM4EKMT2A | |
| SCHEMBL13172621 | 0.75 | GAA (0.53) | GAAL3MBTL1KDM4EKMT2AALDH1A1 | |
| SCHEMBL20467792 | 0.75 | GAA (0.40) | GAAL3MBTL1KDM4EKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230402605-A1 | ELECTROCHEMICAL BATTERY WITH A BIPOLAR ARCHITECTURE COMPRISING A MATERIAL COMMON TO ALL OF THE ELECTRODES AS ELECTRODE ACTIVE MATERIAL | COMMISSARIAT À L'ENERGIE ATOMIQUE ET AUX ÉNERGIES ALTERNATIVES (FR) | 2023-12-14 | — | — | US | disclosed |
| EP-3588634-B1 | IMPROVED ORGANIC ELECTRODE MATERIAL | INNOVATIONLAB GMBH (DE) | 2023-11-22 | — | — | EP | disclosed |
| US-20230253563-A1 | ELECTROACTIVE MATERIALS FOR SECONDARY BATTERIES | UCHICAGO ARGONNE, LLC (US) | 2023-08-10 | — | — | US | disclosed |
| US-20230144767-A1 | TARGETED NITROXIDE AGENTS | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2023-05-11 | — | — | US | disclosed |
| US-11472790-B2 | Dinitroxide biradical compounds as polarizing agents | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2022-10-18 | — | — | US | disclosed |
| EP-2984084-B1 | HIGHLY EFFICIENT POLARIZING AGENTS FOR DYNAMIC NUCLEAR POLARIZATION | BRUKER FRANCE S A S (FR) | 2022-05-04 | — | — | EP | disclosed |
| US-20210371460-A1 | TARGETED NITROXIDE AGENTS | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2021-12-02 | — | — | US | disclosed |
| WO-2021197876-A1 | A SOLUTION OF TEMPO-DERIVATIVES FOR USE AS ELECTROLYTE IN REDOX-FLOW CELLS | BASF SE (DE) | 2021-10-07 | — | — | WO | disclosed |
| US-11001697-B2 | Non-halogenated flame retardant hindered amine light stabilizer cross-linkers | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2021-05-11 | — | — | US | disclosed |
| US-20200317730-A1 | TARGETED NITROXIDE AGENTS | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2020-10-08 | — | — | US | disclosed |
| US-20070093607-A1 | Modified butyl rubber composition | THE YOKOHAMA RUBBER CO., LTD. (JP) | 2007-04-26 | — | — | US | disclosed |
| EP-1777237-A1 | Modified butyl rubber composition | The Yokohama Rubber Co., Ltd. (JP) | 2007-04-25 | — | — | EP | disclosed |
| US-7196144-B2 | Process for modification of polymer | THE YOKOHAMA RUBBER CO., LTD. (JP) | 2007-03-27 | — | — | US | disclosed |
| WO-2007016136-A2 | ORGANIC NITRIC OXIDE ENHANCING SALTS OF CYCLOOXYGENASE-2 SELECTIVE INHIBITORS, COMPOSITONS AND METHODS OF USE | NITROMED, INC. (US) | 2007-02-08 | — | — | WO | disclosed |
| WO-2006099058-A2 | ORGANIC NITRIC OXIDE ENHANCING SALTS OF ANGIOTENSIN II ANTAGONISTS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2006-09-21 | — | — | WO | disclosed |
| US-7071168-B2 | Anti-cancer compounds and methods related thereto | THE REGENTS OF THE UNIVERSITY OF COLORADO (US) | 2006-07-04 | — | — | US | disclosed |
| US-6660181-B2 | Inhibiting the premature polymerization of ethylenically unsaturated monomers by adding mixture comprising a first inhibitor comprising 4-amino-2,2,6,6-tetramethylpiperidinyloxy and other inhibitor | CROMPTON CORPORATION | 2003-12-09 | — | — | US | disclosed |
| US-20030080318-A1 | Inhibition of polymerization of unsaturated monomers | ADDIVANT USA, LLC | 2003-05-01 | — | — | US | disclosed |
| US-6388054-B1 | AMINO ACID SEQUENCES OF ANTITUMOR AGENTS AND APOPTOSIS AGENTS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2002-05-14 | — | — | US | disclosed |
| WO-2000011022-A1 | ANTI-CANCER COMPOUNDS AND METHODS RELATED THERETO | STEWART JOHN M (US) | 2000-03-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11472790-B2 | Dinitroxide biradical compounds as polarizing agents | NDC1, NUCB2, MDM4 | GAA 2894/4885L3MBTL1 1320/4885KDM4E 2856/4885 |
| US-20200317730-A1 | TARGETED NITROXIDE AGENTS | TXNRD2, TXN2, HSPE1 | GAA 2457/4885L3MBTL1 1197/4885KDM4E 2171/4885 |
| US-11001697-B2 | Non-halogenated flame retardant hindered amine light stabilizer cross-linkers | PFAS, FRS2, TST | GAA 3496/4885L3MBTL1 394/4885KDM4E 356/4885 |
| US-20230144767-A1 | TARGETED NITROXIDE AGENTS | TXNRD2, TXN2, HSPE1 | GAA 2457/4885L3MBTL1 1197/4885KDM4E 2171/4885 |
| US-20210371460-A1 | TARGETED NITROXIDE AGENTS | TXNRD2, TXN2, HSPE1 | GAA 2457/4885L3MBTL1 1197/4885KDM4E 2171/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.